Skip to main content
Clinical Trials/IRCT20210227050510N1
IRCT20210227050510N1RecruitingPhase 3

A comparison of the effect of receiving albumin in the initial 8 to 12 hours and after 24 hours after burn on the incidence of fluid creep in severe burn patients

Rasht University of Medical Sciences0 sites96 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
Phase 3
Status
Recruiting
Sponsor
Enrollment
96

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
1 year to no limit (—)
Sex
All

Inclusion Criteria

  • burn patients with 2nd and 3rd degree burn area more than 20 percent TBSA
  • full-thickness burn area more than 10 percent TBSA
  • patients needing vasopressor usage in the first 24 hours of admission
  • patients needing intubation and mechanical ventilation in the first 24 hours of admission

Exclusion Criteria

  • patients not needing albumin infusion according to the clinical decision of specialist
  • critically ill patients with expected death in first 24 hours or patients that expired in first 24 hours of admission
  • brain death in first 24 hours
  • patients admitted more than 8 hours after burn
  • patients with chronic underlying diseases affecting serum albumin level, including nephrotic syndrome, cirrhosis, malnutrition, exudative enteropathy
  • a history of cardiac surgery or myocardial infarction in recent 5 years
  • patients with high-voltage electrical burn injuries
  • patient does not accept entering the study
  • patients receiving plasmaphresis
  • a history of reaction to human albumin

Investigators

Sponsor
Rasht University of Medical Sciences

Similar Trials

An evaluation of the effect of albumin... | Clinical Trial